Align Technology credits a 25% uptick in sales of its Invisalign clear aligner for Q4 and full-year earnings that beat Wall Street's expectations.
California's Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street's expectations.
OrthoAccel raised $5 million through an equity sale, to support its AcceleDent.OrthoAccel Technologies says it raised $5 million in an equity offering to back its AcceleDent sonic orthodontic device.
OrthoAccel Technologies said it brought in $5 million in an equity offering.
The Houston-based company makes the AccelaDent device, which is designed to accelerate tooth movement using sonic technology.
The $5 million came from existing backers Healthpoint Capital and S3 Ventures, along with standing stockholders, according to a press release.
Henry Schein acquires 5 dental software, lab and distribution business from Belgium's Arseus for an undisclosed amount.
Healthcare giant Henry Schein (NSDQ:HSIC) agreed to pay an undisclosed amount to acquire 5 dental businesses from Belgium-based Arseus, the companies announced this week.
Align Technology, its CEO and its CFO managed to dodge a federal class action lawsuit accusing them of reaping millions through insider trading while misstating the dental devices maker's financial position.
Dental implant maker Implant Direct Manufacturing faces sanctions stemming from a magistrate judge's ruling that it destroyed evidence in a patent infringement lawsuit filed by Zest IP Holdings.
Implant Direct Manufacturing will face sanctions for destroying evidence in a patent infringement lawsuit filed by Zest IP Holdings, a federal magistrate judge ruled this week.
Henry Schein Inc. says it plans to acquire a 60% stake in dental implant maker BioHorizons for an undisclosed amount.
Henry Schein (NSDQ:HSIC) said it plans to pick up a 60% stake in dental implant maker BioHorizons for an undisclosed amount.
Company officials at Dentsply International discuss the company's 3rd quarter 2013 earnings report. Dentsply posted profits of $79.9 million, or 55¢ per share, on sales of $704.0 million for the 3 months ended Sept. 30.